Pramipexole for the treatment of restless legs syndrome.

  title={Pramipexole for the treatment of restless legs syndrome.},
  author={Clete Kushida},
  journal={Expert opinion on pharmacotherapy},
  volume={7 4},
Restless legs syndrome (RLS) is a common disorder that is estimated to affect 10% of Americans. However, it remains largely undiagnosed and untreated by clinicians. The primary symptoms of this condition are leg discomfort or an urge to move that is temporarily relieved by movement and is worse at rest and at bedtime. RLS impacts the quality of life of the sufferer by disrupting sleep and disturbing or curtailing work and social activities. Approximately 80% of RLS sufferers also have periodic… CONTINUE READING